Use of cytomegalovirus antigenemia as a marker for preemptive treatment.

Guirado, L

Use of cytomegalovirus antigenemia as a marker for preemptive treatment. [electronic resource] - Transplantation proceedings Feb 2002 - 67-8 p. digital

Publication Type: Journal Article

0041-1345

10.1016/s0041-1345(01)02668-9 doi


Administration, Oral
Adult
Antigens, Viral--blood
Biomarkers--blood
Cytomegalovirus Infections--diagnosis
Drug Therapy, Combination
Ganciclovir--administration & dosage
Humans
Immunosuppressive Agents--therapeutic use
Injections, Intravenous
Kidney Transplantation--immunology
Phosphoproteins--blood
Postoperative Complications--virology
Viral Matrix Proteins--blood